Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Basic Clin Pharmacol Toxicol ; 123(4): 435-442, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29736913

RESUMO

There are many studies that have sought to find drug therapies to prevent harm arising from sepsis. Such studies have represented a progress in the support to septic patients and also in the development of new pharmacological alternatives. Our interest was to investigate the caffeine effect on sepsis behavioural and memory impairments. Male rats were anaesthetized and the surgery was made to allow exposure of the caecum, which was then squeezed to extrude a small amount of faeces from the perforation site, which was later placed back into the peritoneal cavity. This procedure, which served to generate experimental sepsis, is herein referred to as ceccum ligation and perforation (CLP). The caffeine (10 mg/kg) was administered by gavage route, once daily, during 7 or 14 consecutive days to investigate the effects of acute or subchronic caffeine treatment on long-term behavioural and cognitive deficits induced by CLP. On the last day, 1 hr after caffeine administration, the animals were submitted to open-field, elevated plus maze (EPM), forced swimming and step-down inhibitory avoidance tests. The results showed that caffeine increased the percentage of open arm entries and open arm time in the EPM test, and reduced the immobility time when compared to the sham-operated group. The caffeine also increased the latency in the inhibitory avoidance test platform. Our results demonstrated that the caffeine improved behavioural changes and improved the neurocognitive deficits of sepsis-surviving animals. It is possible that blockage of the adenosine receptors may be responsible for the results here observed.


Assuntos
Comportamento Animal/efeitos dos fármacos , Cafeína/farmacologia , Transtornos Cognitivos/prevenção & controle , Cognição/efeitos dos fármacos , Antagonistas de Receptores Purinérgicos P1/farmacologia , Sepse/tratamento farmacológico , Animais , Transtornos Cognitivos/microbiologia , Transtornos Cognitivos/psicologia , Modelos Animais de Doenças , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Memória/efeitos dos fármacos , Atividade Motora/efeitos dos fármacos , Ratos Wistar , Tempo de Reação/efeitos dos fármacos , Sepse/complicações , Sepse/microbiologia , Sepse/psicologia , Fatores de Tempo
3.
Eur J Pharmacol ; 697(1-3): 158-64, 2012 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-23085269

RESUMO

Pneumococcal meningitis is a life-threatening disease characterized by an acute infection affecting the pia matter, arachnoid and subarachnoid space. The intense inflammatory response is associated with a significant mortality rate and neurologic sequelae, such as, seizures, sensory-motor deficits and impairment of learning and memory. The aim of this study was to evaluate the effects of acute and extended administration of cannabidiol on pro-inflammatory cytokines and behavioral parameters in adult Wistar rats submitted to pneumococcal meningitis. Male Wistar rats underwent a cisterna magna tap and received either 10µl of sterile saline as a placebo or an equivalent volume of S. pneumoniae suspension. Rats subjected to meningitis were treated by intraperitoneal injection with cannabidiol (2.5, 5, or 10mg/kg once or daily for 9 days after meningitis induction) or a placebo. Six hours after meningitis induction, the rats that received one dose were killed and the hippocampus and frontal cortex were obtained to assess cytokines/chemokine and brain-derived neurotrophic factor levels. On the 10th day, the rats were submitted to the inhibitory avoidance task. After the task, the animals were killed and samples from the hippocampus and frontal cortex were obtained. The extended administration of cannabidiol at different doses reduced the TNF-α level in frontal cortex. Prolonged treatment with canabidiol, 10mg/kg, prevented memory impairment in rats with pneumococcal meningitis. Although descriptive, our results demonstrate that cannabidiol has anti-inflammatory effects in pneumococcal meningitis and prevents cognitive sequel.


Assuntos
Anti-Inflamatórios/farmacologia , Canabidiol/farmacologia , Transtornos Cognitivos/prevenção & controle , Cognição/efeitos dos fármacos , Lobo Frontal/efeitos dos fármacos , Hipocampo/efeitos dos fármacos , Mediadores da Inflamação/metabolismo , Meningite Pneumocócica/tratamento farmacológico , Animais , Anti-Inflamatórios/administração & dosagem , Comportamento Animal/efeitos dos fármacos , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Canabidiol/administração & dosagem , Quimiocina CXCL1/metabolismo , Transtornos Cognitivos/imunologia , Transtornos Cognitivos/microbiologia , Transtornos Cognitivos/fisiopatologia , Transtornos Cognitivos/psicologia , Modelos Animais de Doenças , Regulação para Baixo , Lobo Frontal/imunologia , Lobo Frontal/microbiologia , Lobo Frontal/fisiopatologia , Hipocampo/imunologia , Hipocampo/microbiologia , Hipocampo/fisiopatologia , Injeções Intraperitoneais , Interleucina-1beta/metabolismo , Interleucina-6/metabolismo , Masculino , Memória/efeitos dos fármacos , Meningite Pneumocócica/imunologia , Meningite Pneumocócica/microbiologia , Meningite Pneumocócica/fisiopatologia , Meningite Pneumocócica/psicologia , Ratos , Ratos Wistar , Streptococcus pneumoniae/imunologia , Fatores de Tempo , Fator de Necrose Tumoral alfa/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA